Related Experiment Video

Updated: Apr 26, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.6K

Medulloblastoma treatment in a child on dialysis

Nadia Puma1, Veronica Biassoni, Lorenza Gandola

  • 1Pediatrics Unit, Fondazione IRCCS, Istituto Nazionale Tumori, Via Giacomo Venezian 1, 20133 Milan, Italy.

CNS Oncology
|July 24, 2014
PubMed

Insights

This case study details the first use of chemotherapy during hemodialysis for a child with medulloblastoma. The treatment effectively managed the cancer in a young patient with end-stage renal disease, showing good remission and tolerability.

Area of Science:

  • Pediatric Oncology
  • Nephrology
  • Clinical Pharmacology

Background:

  • Managing pediatric cancer patients with end-stage renal disease (ESRD) presents unique challenges due to limited data.
  • Adjuvant chemotherapy protocols for pediatric medulloblastoma in children undergoing dialysis are not established.

Observation:

  • A 5-year-old Italian boy with chronic renal failure requiring hemodialysis was diagnosed with desmoplastic medulloblastoma.
  • The tumor exhibited extensive nodularity and nuclear beta-catenin expression, indicating a specific subtype.

Findings:

  • The patient received craniospinal irradiation post-surgical resection, followed by six cycles of cyclophosphamide and vincristine chemotherapy.
  • Vincristine was dosed normally, while cyclophosphamide was administered at 50% dosage after dialysis, extending over the following day.
  • This regimen demonstrated successful disease remission without additional toxicity, marking the first instance of chemotherapy during hemodialysis for pediatric medulloblastoma.

Implications:

  • Chemotherapy administration during hemodialysis is feasible and safe for pediatric medulloblastoma patients with ESRD.
  • This approach offers a viable treatment option, potentially improving outcomes for this vulnerable patient population.
  • Further research is warranted to establish standardized protocols for chemotherapy in pediatric cancer patients with renal compromise.

More Related Videos

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells06:32

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

16.0K
Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice05:10

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

11.6K

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
3.0K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
400
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
2.1K
Dialysis01:15

Dialysis

Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
2.1K
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
1.7K
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
2.1K